Exploring the long-term effects of NMDAR encephalitis
Social and Psychological Long-term Impact of NMDA Receptor Encephalitis
Hospices Civils de Lyon · NCT06609044
This study looks at how NMDAR encephalitis affects people's thinking, emotions, and social lives over time to help improve care and support for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Hospices Civils de Lyon (other) |
| Locations | 1 site (Bron) |
| Trial ID | NCT06609044 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the long-term cognitive, psychological, and social consequences of NMDAR encephalitis, a rare autoimmune neurological disease. It aims to characterize the patient's journey through the disease and develop a standardized neuropsychological assessment to enhance post-acute care. By gathering data on the psychosocial impact of the disease, the study seeks to improve patient management and inform specific medical recommendations for better long-term outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with NMDAR encephalitis.
Not a fit: Patients without NMDAR encephalitis or those with pre-existing neurological disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and support for patients recovering from NMDAR encephalitis.
How similar studies have performed: While there have been few cohort studies on NMDAR encephalitis, this specific focus on long-term psychosocial outcomes is novel and largely untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with NMDAR encephalitis * Age ≥ 18 years old * Patient affiliated to a social security system * No opposition from the patient Exclusion Criteria: * Patients whithout NMDAR encephalitis * Age \< 18 years old * Patient under guardianship or curatorship * Patient with neurological disorders pre-existing encephalitis
Where this trial is running
Bron
- Centre de référence des syndromes neurologies paranéoplasiques et encéphalites auto-immunes - Hôpital neurologiques Pierre WERTHEIMER — Bron, France (RECRUITING)
Study contacts
- Principal investigator: Jérôme HONNORAT, MD — Centre de référence des syndromes neurologies paranéoplasiques et encéphalites auto-immunes - Hôpital neurologiques Pierre WERTHEIMER - Groupement hospitalier Est - Hospices civiles de Lyon
- Study coordinator: Jérôme JH HONNORAT, MD
- Email: jerome.honnorat@chu-lyon.fr
- Phone: 0472357806
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Autoimmune Encephalitis, NMDAR encephalitis, psychosocial impact